TECHNOLOGY SUMMARY

A single use, self-administered, dissolving microneedle array for site specific pain relief without the need of a healthcare professional. The sharps-free microneedle array provides rapid intradermal delivery without pain, bleeding, or bruising. A modified version is currently used by CDC, NIH, and UNICEF for vaccines in developing countries.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Proven Manufacturability

Technology Readiness Level: TRL 6

Vetted Programs/Awards: Isosceles was awarded first prize in the North Carolina Biotech Venture Challenge and received $20,000 grant for top prize. Isosceles has also won awards from business journals and non-profits.

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Website: https://isoscelespharma.com/

Showcase Booth: 525T

MARKET KEYWORDS

Market Keywords: Anti-inflammatory, Nonopioid pain relief, Medically Underserved Areas